Shares of Bausch Health, formerly Valeant, rise 3% on FDA approval of psoriasis treatment

Health, Fitness & Food

Bausch Health, formerly known as Valeant Pharmaceuticals, said Thursday that it and its dermatology business, Ortho Dermatologics received approval from the Food and Drug Administration for its DUOBRII lotion to treat plaque psoriasis.

This article was originally published by Cnbc.com. Read the original article here.

Advertisements